Meningococcal meningitis Symptoms, Prevention, Causative agent
Meningococcal meningitis is observed worldwide; the highest burden of the disease is in the meningitis belt of sub-Saharan Africa, stretching from Senegal in the west to Ethiopia in the east. Meningococcal meningitis is associated with high fatality (50% when untreated) and high frequency (10-20%) of severe long-term sequelae. Early antibiotic treatment is the most important measure to save lives and reduce complications. Serogroup specific vaccines are used for prevention and in response to outbreaks. Since 2010 and the roll-out of a meningococcal A conjugate vaccine through mass preventive immunization campaigns in the meningitis belt, the proportion of the A serogroup has declined dramatically.
Causative agent :
Signs and symptoms:
Headache, vomiting, stiff neck and progress within a few hours
Mode of Transmission
Prevention and Control
Penicillin is the drug of choice
Chemoprophylaxis is suggested for close contact persons.
Prevention of overcrowding is a long term measure
F Y D Pharm Notes, Books, Syllabus, PDF, Videos
Roll on deodrant base ingredients
Use Aartificial Intelligence for optimisation of pharmaceutical formulation
Bayesian approch for optimisation of pharmaceutical formulation